Gleason Group’s AbbVie ABBV Stock Holding History

Gleason Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$55.4K	Buy	220 +127	+137%	+$27.3K	﹤0.01%	133
2026 Q1	$20.3K	Hold	93	–	–	﹤0.01%	152
2025 Q4	$21.2K	Buy	93 +1	+1%	+$228	﹤0.01%	156
2025 Q3	$21.3K	Buy	92 +1	+1%	+$204	﹤0.01%	144
2025 Q2	$16.9K	Buy	91 +1	+1%	+$186	﹤0.01%	152
2025 Q1	$19K	Hold	90	–	–	﹤0.01%	145
2024 Q4	$15.9K	Buy	90 +1	+1%	+$184	﹤0.01%	152
2024 Q3	$17.6K	Sell	89 -29	-25%	-$5.41K	﹤0.01%	146
2024 Q2	$20.3K	Buy	118 +1	+0.9%	+$166	﹤0.01%	162
2024 Q1	$21.3K	Buy	117 +1	+0.9%	+$172	﹤0.01%	143
2023 Q4	$18K	Buy	116 +1	+0.9%	+$146	﹤0.01%	152
2023 Q3	$17.1K	Buy	115 +1	+0.9%	+$147	﹤0.01%	159
2023 Q2	$15.3K	Buy	114 +1	+0.9%	+$147	﹤0.01%	166
2023 Q1	$17.9K	Buy	113 +83	+277%	+$12.7K	0.01%	152
2022 Q4	$4.77K	Sell	30 -123	-80%	-$18.9K	﹤0.01%	192
2022 Q3	$21K	Buy	153 +126	+467%	+$18.1K	0.01%	143
2022 Q2	$4K	Hold	27	–	–	﹤0.01%	202
2022 Q1	$4K	Hold	27	–	–	﹤0.01%	191
2021 Q4	$4K	Hold	27	–	–	﹤0.01%	182
2021 Q3	$3K	Buy	27 +1	+4%	+$114	﹤0.01%	185
2021 Q2	$3K	Hold	26	–	–	﹤0.01%	181
2021 Q1	$3K	Hold	26	–	–	﹤0.01%	179
2020 Q4	$3K	Sell	26 -488	-95%	-$46.9K	﹤0.01%	174
2020 Q3	$45K	Buy	514 +6	+1%	+$565	0.03%	95
2020 Q2	$50K	Buy	508 +6	+1%	+$528	0.03%	87
2020 Q1	$38K	Buy	502 +6	+1%	+$511	0.03%	91
2019 Q4	$44K	Buy	+496	New	+$41.2K	0.03%	103

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Gleason Group's ABBV Position: Q2 2026 in Review

Gleason Group increased its AbbVie (ABBV) stake by 137% in Q2 2026, buying an estimated $27.3K and bringing the position to 220 shares worth $55.4K. The position accounts for ﹤0.01% of the portfolio, ranked #133.

Gleason Group first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Gleason Group held 220 shares of AbbVie worth $55.4K as of Q2 2026.
Gleason Group bought 127 AbbVie shares in Q2 2026, an estimated $27.3K.
AbbVie made up ﹤0.01% of Gleason Group's portfolio in Q2 2026, its #133 holding.
Gleason Group first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Gleason Group's 13F filing for Q2 2026, filed 13 Jul 2026.